Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. infla-aid

INFLA-AID SIGNED

The role of NLRC4 inflammasome in autoinflammatory diseases

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 INFLA-AID project word cloud

Explore the words cloud of the INFLA-AID project. It provides you a very rough idea of what is the project "INFLA-AID" about.

vary    infection    protective    knock    nlrc4    organs    platforms    limited    attributed    life    host    activating    levels    clinical    substances    joined    begins    restricted    lab    alters    vivo    animals    first    function    symptoms    mutations    activate    1b    molecular    toxic    promotes    hyperactivation    protein    amongst    diseases    pro    breeding    types    hyperactivated    downstream    cell    mutant    closely    regulated    caspase    unravel    eliminate    pathogenic    onset    provokes    inflammasomes    disease    lamkanfi    array    administered    flag    systematic    cytokines    acumen    threatening    models    innate    multiprotein    il    mitigate    mechanism    bacterial    provides    inflammasomopathies    expression    except    vigorously    mouse    aetiology    autoinflammatory    mice    inflammasome    manifestation    mutation    aid    immune    inflammatory    microbes    patterns    deficient    causes    overproduction    proinflammatory    pathogenesis    patients    gain    mediated    aberrant    signalling    locate    infancy    initiates    inhibitors    cytokine    clinicians    data    components    inflammation   

Project "INFLA-AID" data sheet

The following table provides information about the project.

Coordinator		 VIB VZW 

Organization address
address: RIJVISSCHESTRAAT 120
city: ZWIJNAARDE - GENT
postcode: 9052
website: www.vib.be

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Belgium [BE]
 Total cost 172˙800 €
 EC max contribution 172˙800 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2018
 Duration (year-month-day) from 2018-10-01   to  2021-01-29

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VIB VZW BE (ZWIJNAARDE - GENT) coordinator 172˙800.00

Map

 Project objective

'Our immune system provides a protective mechanism to control and eliminate elements from pathogenic microbes and toxic substances. Upon bacterial infection, our innate immune system initiates a pro-inflammatory response by activating the 'inflammasomes'. These multiprotein platforms activate caspase-1 to produce proinflammatory cytokines. An array of highly regulated inflammasome-mediated signalling pathways are identified. When the signalling pathway is hyperactivated, overproduction of the downstream cytokines provokes autoinflammatory diseases (AID). Recently, gain-of-function mutations in the NLRC4 inflammasome have been attributed for the manifestation of NLRC4-associated AID (NLRC4-AID). The clinical symptoms vary in these patients, except that the onset of life-threatening systematic inflammation begins at infancy. What is common amongst the NLRC4-AID patients is their limited response to IL-1b inhibitors typically administered for AID. I have joined the Lamkanfi lab to unravel the aetiology and pathogenesis of the NLRC4-AID. While the NLRC4 inflammasome has been vigorously studied at the molecular level, in vivo data are restricted to knock-out mouse models. Using the NLRC4-Flag knock-in mice, I will analyse in vivo NLRC4 protein levels and expression patterns to locate organs and cell types important for NLRC4-mediated inflammation. Next, NLRC4 mutant mice generated in the host lab will be used to identify how the hyperactivation of NLRC4 alters its signalling pathway and promotes AID. The role of downstream cytokine signalling will be assessed by breeding NLRC4 mutant mice to animals deficient in various immune components, which are available from the host institute. This study will provide first acumen into how an NLRC4 mutation causes an autoinflammatory disease, and will contribute to a better understanding of inflammasomopathies. By working closely with clinicians, we aim to mitigate the symptoms in patients with aberrant NLRC4 inflammasome activities.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "INFLA-AID" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "INFLA-AID" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

CODer (2020)

The molecular basis and genetic control of local gene co-expression and its impact in human disease

Read More  

LiverMacRegenCircuit (2020)

Elucidating the role of macrophages in liver regeneration and tissue unit formation

Read More  

SSHelectPhagy (2019)

Regulation of Selective autophagy by sulfide through persulfidation of protein targets.

Read More